Hiroshima University Hospital continues to take all possible infection control measures to prevent the spread of COVID-19 and to ensure the safety of patients and visitors. Therefore, in order to ensure the safety during transportation of those who wish to receive PEP prescription (post-exposure prophylaxis of anti-HIV drugs) at our hospital at their own expense, those who are currently living in areas that have been declared a state of emergency or are subject to pre-emergency measures, or those who have had sexual intercourse in such areas, may be asked to refrain from coming to our hospital. Thank you for your understanding.
Hiroshima University Hospital
PEP, an abbreviation for Post-Exposure Prophylaxis, is a prevention strategy for HIV infection. If you may have been exposed to HIV, you are required to take anti-HIV drugs used for HIV infection treatment within 72 hours of exposure. The medication should be taken once or twice a day for 30 days.
Eligibility for PEP
Those who have sexual contact with a HIV-positive person or a person at risk of HIV infection without the use of a condom within the last 72 hours
Non-Eligibility for PEP
Those who are infected with HIV and who have sexual contact with a known HIV-negative person are not eligible for PEP.
For PEP treatment for healthcare professionals who have experienced a needlestick injury at work, please contact the health promotion division of the prefectural government where the relevant medical or welfare institution is located, our hospital, or a nearby AIDS core hospital. (For those in Hiroshima Prefecture, please visit this website: https://www.pref.hiroshima.lg.jp/site/hcdc/1168502579849.html)